Alphabet Inc’s Autolus Therapeutics AUTL Stock Holding History

Alphabet Inc’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.12M	Hold	698,262	–	–	﹤0.01%	28
2026 Q1	$964K	Hold	698,262	–	–	0.02%	25
2025 Q4	$1.39M	Hold	698,262	–	–	0.05%	24
2025 Q3	$1.14M	Hold	698,262	–	–	0.05%	32
2025 Q2	$1.59M	Hold	698,262	–	–	0.07%	25
2025 Q1	$1.08M	Hold	698,262	–	–	0.07%	29
2024 Q4	$1.64M	Hold	698,262	–	–	0.1%	25
2024 Q3	$2.53M	Hold	698,262	–	–	0.14%	25
2024 Q2	$2.43M	Hold	698,262	–	–	0.12%	27
2024 Q1	$4.45M	Hold	698,262	–	–	0.18%	27
2023 Q4	$4.5M	Hold	698,262	–	–	0.21%	26
2023 Q3	$1.63M	Hold	698,262	–	–	0.1%	33
2023 Q2	$1.66M	Hold	698,262	–	–	0.09%	35
2023 Q1	$1.28M	Hold	698,262	–	–	0.07%	38
2022 Q4	$1.33M	Hold	698,262	–	–	0.08%	43
2022 Q3	$1.49M	Hold	698,262	–	–	0.08%	41
2022 Q2	$1.98M	Hold	698,262	–	–	0.11%	43
2022 Q1	$2.91M	Hold	698,262	–	–	0.09%	46
2021 Q4	$3.62M	Hold	698,262	–	–	0.09%	46
2021 Q3	$4.57M	Hold	698,262	–	–	0.11%	37
2021 Q2	$4.64M	Hold	698,262	–	–	0.09%	31
2021 Q1	$4M	Hold	698,262	–	–	0.16%	29
2020 Q4	$6.24M	Hold	698,262	–	–	0.3%	25
2020 Q3	$8.13M	Hold	698,262	–	–	0.38%	15
2020 Q2	$11.2M	Sell	698,262 -1,090	-0.2%	-$12.1K	0.52%	14
2020 Q1	$4.19M	Hold	699,352	–	–	0.27%	19
2019 Q4	$9.23M	Hold	699,352	–	–	0.56%	15
2019 Q3	$8.69M	Hold	699,352	–	–	0.26%	11
2019 Q2	$11.3M	Sell	699,352 -14,720	-2%	-$329K	0.21%	13
2019 Q1	$22.5M	Hold	714,072	–	–	1.16%	8
2018 Q4	$23.4M	Hold	714,072	–	–	2.77%	8
2018 Q3	$21.9M	Hold	714,072	–	–	2.1%	10
2018 Q2	$19.1M	Buy	+714,072	New	+$18.9M	1.61%	9

Other funds holding AUTL

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Alphabet Inc's AUTL Position: Q2 2026 in Review

Alphabet Inc held its Autolus Therapeutics (AUTL) position steady in Q2 2026 at 698,262 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #28.

Alphabet Inc first reported a position in AUTL in Q2 2018 and has held it in 33 quarters since. The position peaked at $23.4M in Q4 2018. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

Alphabet Inc held 698,262 shares of Autolus Therapeutics worth $1.12M as of Q2 2026.
Alphabet Inc left its Autolus Therapeutics share count unchanged in Q2 2026.
Autolus Therapeutics made up ﹤0.01% of Alphabet Inc's portfolio in Q2 2026, its #28 holding.
Alphabet Inc first reported a position in Autolus Therapeutics in Q2 2018 and has held it in 33 quarters since.
Alphabet Inc's Autolus Therapeutics position peaked at $23.4M in Q4 2018.
84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Alphabet Inc's 13F filing for Q2 2026, filed 7 Aug 2026.